On June 16, 2017, Cigna Corporation (“Cigna”) received notification from the Centers for Medicare & Medicaid Services (“CMS”) that the marketing and enrollment sanctions imposed by CMS on January 21, 2016, have been lifted. Effective immediately, Cigna may resume marketing of its Medicare Advantage-Prescription Drug and Medicare Part D Plans and may begin enrolling beneficiaries with effective dates beginning July 1, 2017.

In addition, based on the final Medicare Star Ratings for the 2018 payment year, we expect that approximately 60% of our Medicare Advantage customers will be in a 4 Star or greater plan.

About Cigna Corporation (NYSE:CI)

Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, Other Operations and Corporate. The Global Health Care segment aggregates the commercial and Government operating segments. The Global Supplemental Benefits segment offers supplemental health, life and accident insurance products primarily in Asia, Europe and the United States. The Company’s Global Supplemental Benefits segment offers supplemental health, life and accident insurance products primarily in Asia, Europe and the United States. Its products are offered through employers and other groups, such as Governmental and non-Governmental organizations, unions and associations. Cigna also offers commercial health and dental insurance, and Medicare and Medicaid products and health.